HVT Medical

Advanced Transcatheter Aortic Valve Implantation Device

Health Tech & Life Sciences
Active
Seed Ramat Yishai Founded 2022
Total raised
$1.5M
Last: Undisclosed
Stage
Seed
Founded
2022
Headcount
3
HQ
Ramat Yishai
Sector
Health Tech & Life Sciences

About

HVT Medical is focused on finding a solution for patients who are contraindicated for aortic valve implantation due to anatomical limitations.

HVT Medical is developing a device called the Splitter that can be inserted in a catheterization procedure. The device will modify the aortic valve to enable transcatheter valve implantation safely.

HVT Medical's Splitter device performs cusp splitting before a TAVI procedure to help reduce risk of coronary occlusion. The device creates an intentional laceration or excision of valve's cusp tissue by applying an advanced catheter equipped with cutting head that mimics an alligator jaw.

Funding history · 1 round · $1.5M total

Date unknown
Undisclosed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical Equipment
Business model
B2B

Tags

cardiologypatientshealthcaresurgerydigital-healthcarelife-sciencesmedical-deviceshospitalscatheters